Ridgetech Documents
Documents
0
Ticker
RDGT
ISIN
KYG2124G1203
Ridgetech SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Ridgetech Documents 2026
This page contains all official documents and SEC filings for Ridgetech stock (RDGT, ISIN: KYG2124G1203). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Ridgetech's regulatory filings.
Ridgetech Stock analysis
Ridgetech Ridgetech Inc generates revenue through four business segments. The Retail Drugstores segment sells prescription and OTC drugs, supplements, TCM, personal care, medical devices, and convenience products. The Online Pharmacy segment sells OTC drugs, medical devices, and supplements via Alibaba’s Tmall, JD.com, and Amazon.com, plus the company’s own platform. The Drug Wholesale segment supplies retail stores with medicines, TCM, supplements, and sundry items. The Herb Farming segment cultivates herbs for sale to other drug vendors. Customers include pharmacies, online shoppers, and other drug vendors. The company’s products are distributed through its own retail stores, third-party e-commerce platforms, and direct sales to drug vendors. Brands like Alibaba’s Tmall, JD.com, and Amazon.com are used for online sales. The Retail Drugstores segment targets individual consumers for healthcare products, while the Drug Wholesale segment serves other pharmacies. Herb Farming supplies herbs to drug vendors for further distribution. Ridgetech Inc’s revenue streams come from retail sales, online marketplace transactions, wholesale supply, and herb sales. The Retail Drugstores segment serves end consumers, the Online Pharmacy segment serves online shoppers, the Drug Wholesale segment serves other pharmacies, and the Herb Farming segment serves drug vendors. Sales are made through owned stores, third-party platforms, and direct vendor contracts.